{"id":17407,"date":"2026-08-06T09:04:38","date_gmt":"2026-08-06T08:04:38","guid":{"rendered":"https:\/\/romevisionclinic.com\/?p=17407"},"modified":"2026-09-08T12:31:47","modified_gmt":"2026-09-08T11:31:47","slug":"protesi-sottoretinica-marchio-ce","status":"publish","type":"post","link":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/","title":{"rendered":"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"17407\" class=\"elementor elementor-17407\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9dae3d6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9dae3d6\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;shape_divider_top&quot;:&quot;wave-brush&quot;}\">\n\t\t\t\t\t<div class=\"elementor-shape elementor-shape-top\" data-negative=\"false\">\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 283.5 27.8\" preserveAspectRatio=\"none\">\n\t<path class=\"elementor-shape-fill\" d=\"M283.5,9.7c0,0-7.3,4.3-14,4.6c-6.8,0.3-12.6,0-20.9-1.5c-11.3-2-33.1-10.1-44.7-5.7\ts-12.1,4.6-18,7.4c-6.6,3.2-20,9.6-36.6,9.3C131.6,23.5,99.5,7.2,86.3,8c-1.4,0.1-6.6,0.8-10.5,2c-3.8,1.2-9.4,3.8-17,4.7\tc-3.2,0.4-8.3,1.1-14.2,0.9c-1.5-0.1-6.3-0.4-12-1.6c-5.7-1.2-11-3.1-15.8-3.7C6.5,9.2,0,10.8,0,10.8V0h283.5V9.7z M260.8,11.3\tc-0.7-1-2-0.4-4.3-0.4c-2.3,0-6.1-1.2-5.8-1.1c0.3,0.1,3.1,1.5,6,1.9C259.7,12.2,261.4,12.3,260.8,11.3z M242.4,8.6\tc0,0-2.4-0.2-5.6-0.9c-3.2-0.8-10.3-2.8-15.1-3.5c-8.2-1.1-15.8,0-15.1,0.1c0.8,0.1,9.6-0.6,17.6,1.1c3.3,0.7,9.3,2.2,12.4,2.7\tC239.9,8.7,242.4,8.6,242.4,8.6z M185.2,8.5c1.7-0.7-13.3,4.7-18.5,6.1c-2.1,0.6-6.2,1.6-10,2c-3.9,0.4-8.9,0.4-8.8,0.5\tc0,0.2,5.8,0.8,11.2,0c5.4-0.8,5.2-1.1,7.6-1.6C170.5,14.7,183.5,9.2,185.2,8.5z M199.1,6.9c0.2,0-0.8-0.4-4.8,1.1\tc-4,1.5-6.7,3.5-6.9,3.7c-0.2,0.1,3.5-1.8,6.6-3C197,7.5,199,6.9,199.1,6.9z M283,6c-0.1,0.1-1.9,1.1-4.8,2.5s-6.9,2.8-6.7,2.7\tc0.2,0,3.5-0.6,7.4-2.5C282.8,6.8,283.1,5.9,283,6z M31.3,11.6c0.1-0.2-1.9-0.2-4.5-1.2s-5.4-1.6-7.8-2C15,7.6,7.3,8.5,7.7,8.6\tC8,8.7,15.9,8.3,20.2,9.3c2.2,0.5,2.4,0.5,5.7,1.6S31.2,11.9,31.3,11.6z M73,9.2c0.4-0.1,3.5-1.6,8.4-2.6c4.9-1.1,8.9-0.5,8.9-0.8\tc0-0.3-1-0.9-6.2-0.3S72.6,9.3,73,9.2z M71.6,6.7C71.8,6.8,75,5.4,77.3,5c2.3-0.3,1.9-0.5,1.9-0.6c0-0.1-1.1-0.2-2.7,0.2\tC74.8,5.1,71.4,6.6,71.6,6.7z M93.6,4.4c0.1,0.2,3.5,0.8,5.6,1.8c2.1,1,1.8,0.6,1.9,0.5c0.1-0.1-0.8-0.8-2.4-1.3\tC97.1,4.8,93.5,4.2,93.6,4.4z M65.4,11.1c-0.1,0.3,0.3,0.5,1.9-0.2s2.6-1.3,2.2-1.2s-0.9,0.4-2.5,0.8C65.3,10.9,65.5,10.8,65.4,11.1\tz M34.5,12.4c-0.2,0,2.1,0.8,3.3,0.9c1.2,0.1,2,0.1,2-0.2c0-0.3-0.1-0.5-1.6-0.4C36.6,12.8,34.7,12.4,34.5,12.4z M152.2,21.1\tc-0.1,0.1-2.4-0.3-7.5-0.3c-5,0-13.6-2.4-17.2-3.5c-3.6-1.1,10,3.9,16.5,4.1C150.5,21.6,152.3,21,152.2,21.1z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M269.6,18c-0.1-0.1-4.6,0.3-7.2,0c-7.3-0.7-17-3.2-16.6-2.9c0.4,0.3,13.7,3.1,17,3.3\tC267.7,18.8,269.7,18,269.6,18z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M227.4,9.8c-0.2-0.1-4.5-1-9.5-1.2c-5-0.2-12.7,0.6-12.3,0.5c0.3-0.1,5.9-1.8,13.3-1.2\tS227.6,9.9,227.4,9.8z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M204.5,13.4c-0.1-0.1,2-1,3.2-1.1c1.2-0.1,2,0,2,0.3c0,0.3-0.1,0.5-1.6,0.4\tC206.4,12.9,204.6,13.5,204.5,13.4z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M201,10.6c0-0.1-4.4,1.2-6.3,2.2c-1.9,0.9-6.2,3.1-6.1,3.1c0.1,0.1,4.2-1.6,6.3-2.6\tS201,10.7,201,10.6z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M154.5,26.7c-0.1-0.1-4.6,0.3-7.2,0c-7.3-0.7-17-3.2-16.6-2.9c0.4,0.3,13.7,3.1,17,3.3\tC152.6,27.5,154.6,26.8,154.5,26.7z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M41.9,19.3c0,0,1.2-0.3,2.9-0.1c1.7,0.2,5.8,0.9,8.2,0.7c4.2-0.4,7.4-2.7,7-2.6\tc-0.4,0-4.3,2.2-8.6,1.9c-1.8-0.1-5.1-0.5-6.7-0.4S41.9,19.3,41.9,19.3z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M75.5,12.6c0.2,0.1,2-0.8,4.3-1.1c2.3-0.2,2.1-0.3,2.1-0.5c0-0.1-1.8-0.4-3.4,0\tC76.9,11.5,75.3,12.5,75.5,12.6z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M15.6,13.2c0-0.1,4.3,0,6.7,0.5c2.4,0.5,5,1.9,5,2c0,0.1-2.7-0.8-5.1-1.4\tC19.9,13.7,15.7,13.3,15.6,13.2z\"\/>\n<\/svg>\t\t<\/div>\n\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ac6faa7\" data-id=\"ac6faa7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-057a154 elementor-widget elementor-widget-spacer\" data-id=\"057a154\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.20.0 - 26-03-2024 *\/\n.elementor-column .elementor-spacer-inner{height:var(--spacer-size)}.e-con{--container-widget-width:100%}.e-con-inner>.elementor-widget-spacer,.e-con>.elementor-widget-spacer{width:var(--container-widget-width,var(--spacer-size));--align-self:var(--container-widget-align-self,initial);--flex-shrink:0}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container,.e-con>.elementor-widget-spacer>.elementor-widget-container{height:100%;width:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer{height:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner{height:var(--container-widget-height,var(--spacer-size))}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty,.e-con>.elementor-widget-spacer.elementor-widget-empty{position:relative;min-height:22px;min-width:22px}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon,.e-con>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon{position:absolute;top:0;bottom:0;left:0;right:0;margin:auto;padding:0;width:22px;height:22px}<\/style>\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-4e8eca3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4e8eca3\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-0135f02\" data-id=\"0135f02\" data-element_type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-59f3fe3 elementor-toc--minimized-on-tablet elementor-widget elementor-widget-table-of-contents\" data-id=\"59f3fe3\" data-element_type=\"widget\" data-settings=\"{&quot;headings_by_tags&quot;:[&quot;h2&quot;,&quot;h3&quot;],&quot;exclude_headings_by_selector&quot;:[],&quot;marker_view&quot;:&quot;numbers&quot;,&quot;minimize_box&quot;:&quot;yes&quot;,&quot;minimized_on&quot;:&quot;tablet&quot;,&quot;hierarchical_view&quot;:&quot;yes&quot;,&quot;min_height&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;min_height_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;min_height_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"table-of-contents.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor-pro - v3.13.2 - 22-05-2023 *\/\n.elementor-widget-table-of-contents .elementor-toc__header-title{color:var(--header-color)}.elementor-widget-table-of-contents.elementor-toc--collapsed .elementor-toc__toggle-button--collapse,.elementor-widget-table-of-contents:not(.elementor-toc--collapsed) .elementor-toc__toggle-button--expand{display:none}.elementor-widget-table-of-contents .elementor-widget-container{min-height:var(--box-min-height);border:var(--box-border-width,1px) solid var(--box-border-color,#9da5ae);border-radius:var(--box-border-radius,3px);background-color:var(--box-background-color);transition:min-height .4s;overflow:hidden}.elementor-toc__header{display:flex;align-items:center;justify-content:space-between;padding:var(--box-padding,20px);background-color:var(--header-background-color);border-bottom:var(--separator-width,1px) solid var(--box-border-color,#9da5ae)}.elementor-toc__header-title{font-size:18px;margin:0;color:var(--header-color)}.elementor-toc__toggle-button{cursor:pointer;display:inline-flex}.elementor-toc__toggle-button i{color:var(--toggle-button-color)}.elementor-toc__toggle-button svg{height:1em;width:1em;fill:var(--toggle-button-color)}.elementor-toc__spinner-container{text-align:center}.elementor-toc__spinner{font-size:2em}.elementor-toc__spinner.e-font-icon-svg{height:1em;width:1em}.elementor-toc__body{padding:var(--box-padding,20px);max-height:var(--toc-body-max-height);overflow-y:auto}.elementor-toc__body::-webkit-scrollbar{width:7px}.elementor-toc__body::-webkit-scrollbar-thumb{background-color:#babfc5;border-radius:10px}.elementor-toc__list-wrapper{list-style:none;padding:0}.elementor-toc__list-item{margin-bottom:.5em}.elementor-toc__list-item.elementor-item-active{font-weight:700}.elementor-toc__list-item .elementor-toc__list-wrapper{margin-top:.5em;margin-left:var(--nested-list-indent,1em)}.elementor-toc__list-item-text:hover{color:var(--item-text-hover-color);-webkit-text-decoration:var(--item-text-hover-decoration);text-decoration:var(--item-text-hover-decoration)}.elementor-toc__list-item-text.elementor-item-active{color:var(--item-text-active-color);-webkit-text-decoration:var(--item-text-active-decoration);text-decoration:var(--item-text-active-decoration)}.elementor-toc__list-item-text-wrapper{display:flex;align-items:center}.elementor-toc__list-item-text-wrapper:before,.elementor-toc__list-item-text-wrapper i{margin-right:8px;color:var(--marker-color)}.elementor-toc__list-item-text-wrapper svg{margin-right:8px;fill:var(--marker-color);height:var(--marker-size,.5em);width:var(--marker-size,.5em)}.elementor-toc__list-item-text-wrapper i{font-size:var(--marker-size,.5em)}.elementor-toc__list-item-text-wrapper:before{font-size:var(--marker-size,1em)}.elementor-toc--content-ellipsis .elementor-toc__list-item-text{white-space:nowrap;overflow:hidden;text-overflow:ellipsis}.elementor-toc__list-items--collapsible>.elementor-toc__list-wrapper>.elementor-toc__list-item>.elementor-toc__list-wrapper{display:none}.elementor-toc__heading-anchor{position:absolute}.elementor-toc__body .elementor-toc__list-item-text{color:var(--item-text-color);-webkit-text-decoration:var(--item-text-decoration);text-decoration:var(--item-text-decoration)}.elementor-toc__body .elementor-toc__list-item-text:hover{color:var(--item-text-hover-color);-webkit-text-decoration:var(--item-text-hover-decoration);text-decoration:var(--item-text-hover-decoration)}.elementor-toc__body .elementor-toc__list-item-text.elementor-item-active{color:var(--item-text-active-color);-webkit-text-decoration:var(--item-text-active-decoration);text-decoration:var(--item-text-active-decoration)}ol.elementor-toc__list-wrapper{counter-reset:item}ol.elementor-toc__list-wrapper .elementor-toc__list-item{counter-increment:item}ol.elementor-toc__list-wrapper .elementor-toc__list-item-text-wrapper:before{content:counters(item,\".\") \". \"}<\/style>\t\t<div class=\"elementor-toc__header\" aria-controls=\"elementor-toc__body\">\n\t\t\t<h2 class=\"elementor-toc__header-title\">\n\t\t\t\tTabella dei Contenuti\t\t\t<\/h2>\n\t\t\t\t\t\t\t<div class=\"elementor-toc__toggle-button elementor-toc__toggle-button--expand\" role=\"button\" tabindex=\"0\" aria-label=\"Apri l&#039;indice dei contenuti\"><i aria-hidden=\"true\" class=\"fas fa-chevron-down\"><\/i><\/div>\n\t\t\t\t<div class=\"elementor-toc__toggle-button elementor-toc__toggle-button--collapse\" role=\"button\" tabindex=\"0\" aria-label=\"Chiudi l&#039;indice dei contenuti\"><i aria-hidden=\"true\" class=\"fas fa-chevron-up\"><\/i><\/div>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-toc__body\" aria-expanded=\"true\">\n\t\t\t<div class=\"elementor-toc__spinner-container\">\n\t\t\t\t<i class=\"elementor-toc__spinner eicon-animation-spin eicon-loading\" aria-hidden=\"true\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-bd56db1\" data-id=\"bd56db1\" data-element_type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f3cd8d2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f3cd8d2\" data-element_type=\"section\" data-settings=\"{&quot;shape_divider_bottom&quot;:&quot;wave-brush&quot;}\">\n\t\t\t\t\t<div class=\"elementor-shape elementor-shape-bottom\" data-negative=\"false\">\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 283.5 27.8\" preserveAspectRatio=\"none\">\n\t<path class=\"elementor-shape-fill\" d=\"M283.5,9.7c0,0-7.3,4.3-14,4.6c-6.8,0.3-12.6,0-20.9-1.5c-11.3-2-33.1-10.1-44.7-5.7\ts-12.1,4.6-18,7.4c-6.6,3.2-20,9.6-36.6,9.3C131.6,23.5,99.5,7.2,86.3,8c-1.4,0.1-6.6,0.8-10.5,2c-3.8,1.2-9.4,3.8-17,4.7\tc-3.2,0.4-8.3,1.1-14.2,0.9c-1.5-0.1-6.3-0.4-12-1.6c-5.7-1.2-11-3.1-15.8-3.7C6.5,9.2,0,10.8,0,10.8V0h283.5V9.7z M260.8,11.3\tc-0.7-1-2-0.4-4.3-0.4c-2.3,0-6.1-1.2-5.8-1.1c0.3,0.1,3.1,1.5,6,1.9C259.7,12.2,261.4,12.3,260.8,11.3z M242.4,8.6\tc0,0-2.4-0.2-5.6-0.9c-3.2-0.8-10.3-2.8-15.1-3.5c-8.2-1.1-15.8,0-15.1,0.1c0.8,0.1,9.6-0.6,17.6,1.1c3.3,0.7,9.3,2.2,12.4,2.7\tC239.9,8.7,242.4,8.6,242.4,8.6z M185.2,8.5c1.7-0.7-13.3,4.7-18.5,6.1c-2.1,0.6-6.2,1.6-10,2c-3.9,0.4-8.9,0.4-8.8,0.5\tc0,0.2,5.8,0.8,11.2,0c5.4-0.8,5.2-1.1,7.6-1.6C170.5,14.7,183.5,9.2,185.2,8.5z M199.1,6.9c0.2,0-0.8-0.4-4.8,1.1\tc-4,1.5-6.7,3.5-6.9,3.7c-0.2,0.1,3.5-1.8,6.6-3C197,7.5,199,6.9,199.1,6.9z M283,6c-0.1,0.1-1.9,1.1-4.8,2.5s-6.9,2.8-6.7,2.7\tc0.2,0,3.5-0.6,7.4-2.5C282.8,6.8,283.1,5.9,283,6z M31.3,11.6c0.1-0.2-1.9-0.2-4.5-1.2s-5.4-1.6-7.8-2C15,7.6,7.3,8.5,7.7,8.6\tC8,8.7,15.9,8.3,20.2,9.3c2.2,0.5,2.4,0.5,5.7,1.6S31.2,11.9,31.3,11.6z M73,9.2c0.4-0.1,3.5-1.6,8.4-2.6c4.9-1.1,8.9-0.5,8.9-0.8\tc0-0.3-1-0.9-6.2-0.3S72.6,9.3,73,9.2z M71.6,6.7C71.8,6.8,75,5.4,77.3,5c2.3-0.3,1.9-0.5,1.9-0.6c0-0.1-1.1-0.2-2.7,0.2\tC74.8,5.1,71.4,6.6,71.6,6.7z M93.6,4.4c0.1,0.2,3.5,0.8,5.6,1.8c2.1,1,1.8,0.6,1.9,0.5c0.1-0.1-0.8-0.8-2.4-1.3\tC97.1,4.8,93.5,4.2,93.6,4.4z M65.4,11.1c-0.1,0.3,0.3,0.5,1.9-0.2s2.6-1.3,2.2-1.2s-0.9,0.4-2.5,0.8C65.3,10.9,65.5,10.8,65.4,11.1\tz M34.5,12.4c-0.2,0,2.1,0.8,3.3,0.9c1.2,0.1,2,0.1,2-0.2c0-0.3-0.1-0.5-1.6-0.4C36.6,12.8,34.7,12.4,34.5,12.4z M152.2,21.1\tc-0.1,0.1-2.4-0.3-7.5-0.3c-5,0-13.6-2.4-17.2-3.5c-3.6-1.1,10,3.9,16.5,4.1C150.5,21.6,152.3,21,152.2,21.1z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M269.6,18c-0.1-0.1-4.6,0.3-7.2,0c-7.3-0.7-17-3.2-16.6-2.9c0.4,0.3,13.7,3.1,17,3.3\tC267.7,18.8,269.7,18,269.6,18z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M227.4,9.8c-0.2-0.1-4.5-1-9.5-1.2c-5-0.2-12.7,0.6-12.3,0.5c0.3-0.1,5.9-1.8,13.3-1.2\tS227.6,9.9,227.4,9.8z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M204.5,13.4c-0.1-0.1,2-1,3.2-1.1c1.2-0.1,2,0,2,0.3c0,0.3-0.1,0.5-1.6,0.4\tC206.4,12.9,204.6,13.5,204.5,13.4z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M201,10.6c0-0.1-4.4,1.2-6.3,2.2c-1.9,0.9-6.2,3.1-6.1,3.1c0.1,0.1,4.2-1.6,6.3-2.6\tS201,10.7,201,10.6z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M154.5,26.7c-0.1-0.1-4.6,0.3-7.2,0c-7.3-0.7-17-3.2-16.6-2.9c0.4,0.3,13.7,3.1,17,3.3\tC152.6,27.5,154.6,26.8,154.5,26.7z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M41.9,19.3c0,0,1.2-0.3,2.9-0.1c1.7,0.2,5.8,0.9,8.2,0.7c4.2-0.4,7.4-2.7,7-2.6\tc-0.4,0-4.3,2.2-8.6,1.9c-1.8-0.1-5.1-0.5-6.7-0.4S41.9,19.3,41.9,19.3z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M75.5,12.6c0.2,0.1,2-0.8,4.3-1.1c2.3-0.2,2.1-0.3,2.1-0.5c0-0.1-1.8-0.4-3.4,0\tC76.9,11.5,75.3,12.5,75.5,12.6z\"\/>\n\t<path class=\"elementor-shape-fill\" d=\"M15.6,13.2c0-0.1,4.3,0,6.7,0.5c2.4,0.5,5,1.9,5,2c0,0.1-2.7-0.8-5.1-1.4\tC19.9,13.7,15.7,13.3,15.6,13.2z\"\/>\n<\/svg>\t\t<\/div>\n\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-29564d4\" data-id=\"29564d4\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f28f264 elementor-widget elementor-widget-spacer\" data-id=\"f28f264\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c981986 elementor-widget elementor-widget-spacer\" data-id=\"c981986\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-96be2d6 elementor-widget elementor-widget-spacer\" data-id=\"96be2d6\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b5ed243 elementor-widget elementor-widget-text-editor\" data-id=\"b5ed243\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.20.0 - 26-03-2024 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p><b>PRIMA<\/b><span style=\"font-weight: 400;\"> \u00e8 una tecnologia d\u2019avanguardia progettata e realizzata per il trattamento dei pazienti affetti da <\/span><b>degenerazione maculare legata all&#8217;et\u00e0<\/b><span style=\"font-weight: 400;\"> (<\/span><b>maculopatia<\/b><span style=\"font-weight: 400;\">) <\/span><b>di tipo atrofico<\/b><span style=\"font-weight: 400;\"> evoluta allo stadio terminale di <\/span><b>atrofia geografica<\/b><span style=\"font-weight: 400;\">. L&#8217;ottenimento del <\/span><b>marchio CE<\/b><span style=\"font-weight: 400;\"> e il conseguente via libera alla sua commercializzazione permetteranno a PRIMA di entrare nella pratica clinica. Cosa significa questo in concreto per i pazienti affetti da questa patologia?<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5b0002a elementor-widget elementor-widget-text-editor\" data-id=\"5b0002a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Ne parliamo con il\u00a0<\/span><b>Prof. Andrea Cusumano<\/b><span style=\"font-weight: 400;\">, ricercatore dell&#8217;<\/span><b>Universit\u00e0 degli Studi di Roma Tor Vergata <\/b><span style=\"font-weight: 400;\">e <\/span><b>direttore scientifico<\/b><span style=\"font-weight: 400;\"> del gruppo di ricerca italiano che ha preso parte allo studio clinico multicentrico\u00a0<\/span><b>PRIMAvera<\/b><span style=\"font-weight: 400;\">, i cui risultati \u2013 pubblicati sul <\/span><b>New England Journal of Medicine<\/b><span style=\"font-weight: 400;\"> \u2013 hanno contribuito allo sviluppo e all\u2019approvazione del dispositivo.<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b3862fb elementor-widget elementor-widget-heading\" data-id=\"b3862fb\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.20.0 - 26-03-2024 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-default\">Professor Cusumano, perch\u00e9 il marchio CE per PRIMA rappresenta un traguardo cos\u00ec importante?\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4f1a289 elementor-widget elementor-widget-text-editor\" data-id=\"4f1a289\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00abIl marchio CE certifica che il dispositivo soddisfa i requisiti europei di sicurezza e prestazione e ne consente l&#8217;impiego nella pratica clinica. \u00c8 un passaggio fondamentale perch\u00e9 una tecnologia sviluppata e validata attraverso la ricerca clinica possa diventare una concreta opportunit\u00e0 terapeutica per i pazienti che ne hanno indicazione.\u00bb<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bfc435a elementor-widget elementor-widget-heading\" data-id=\"bfc435a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Che cos'\u00e8 PRIMA e come funziona?<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d85aaaa elementor-widget elementor-widget-text-editor\" data-id=\"d85aaaa\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00abPRIMA \u00e8 un <\/span><b>microchip wireless<\/b><span style=\"font-weight: 400;\"> di appena 2\u00d72 millimetri di lato e 30 micron di spessore (circa un terzo di un capello umano), che viene impiantato sotto la retina con un <\/span><b>intervento mini-invasivo<\/b><span style=\"font-weight: 400;\">, generalmente in <\/span><b>anestesia locale<\/b><span style=\"font-weight: 400;\">. Il microchip lavora insieme a un <\/span><b>paio di occhiali<\/b><span style=\"font-weight: 400;\"> dotati di una <\/span><b>mini telecamera <\/b><span style=\"font-weight: 400;\">che cattura le immagini di fronte al paziente, un <\/span><b>processore esterno<\/b><span style=\"font-weight: 400;\"> che elabora le immagini e le trasforma in <\/span><b>pattern luminosi<\/b><span style=\"font-weight: 400;\">, e un <\/span><b>micro-proiettore<\/b><span style=\"font-weight: 400;\"> integrato negli occhiali che invia i pattern luminosi al microchip. Quest\u2019ultimo converte gli stimoli luminosi in <\/span><b>stimoli elettrici<\/b><span style=\"font-weight: 400;\">, che vengono poi trasmessi in modo naturale alle cellule residue della retina e infine, attraverso il <\/span><b>nervo ottico<\/b><span style=\"font-weight: 400;\">, al <\/span><b>cervello<\/b><span style=\"font-weight: 400;\">.\u00bb<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9a33adb elementor-widget elementor-widget-heading\" data-id=\"9a33adb\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Che tipo di visione consente PRIMA?\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6cf3220 elementor-widget elementor-widget-text-editor\" data-id=\"6cf3220\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00abPRIMA elicita la percezione di <\/span><b>lampi luminosi<\/b><span style=\"font-weight: 400;\">, o <\/span><b>fosfeni<\/b><span style=\"font-weight: 400;\">, organizzati spazialmente secondo il pattern inviato al microchip, che rispecchia l\u2019oggetto osservato. Non si tratta di una visione paragonabile a quella naturale e non si tratta di una cura della maculopatia, ma di una <\/span><b>nuova opportunit\u00e0 terapeutica <\/b><span style=\"font-weight: 400;\">per le persone che hanno perso la visione centrale a causa della maculopatia atrofica. La protesi permette infatti il recupero di una visione utile a restituire \u2013 anche grazie a un impegnativo periodo di riabilitazione visiva \u2013 parte dell\u2019autonomia nella vita quotidiana e, in alcuni casi, anche lavorativa.\u00bb<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6fd2121 elementor-widget elementor-widget-heading\" data-id=\"6fd2121\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Qual \u00e8 stato il contributo italiano a questo risultato?\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bb6c1ab elementor-widget elementor-widget-text-editor\" data-id=\"bb6c1ab\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00abLa stretta collaborazione tra l&#8217;<\/span><b>Universit\u00e0 degli Studi di Roma Tor Vergata <\/b><span style=\"font-weight: 400;\">e l&#8217;<\/span><b>Ospedale Britannico di Roma <\/b><span style=\"font-weight: 400;\">\u00e8 riuscita a portare un contributo significativo al progetto PRIMAvera. La ricerca clinica \u00e8 sempre un lavoro di squadra e questo risultato dimostra come la collaborazione tra universit\u00e0, ospedali e centri di ricerca internazionali possa contribuire allo sviluppo di tecnologie innovative con un impatto significativo sulla vita reale delle persone.\u00bb<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aeff3bc elementor-widget elementor-widget-heading\" data-id=\"aeff3bc\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Quali e quanti pazienti potrebbero beneficiarne?\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d8c93ea elementor-widget elementor-widget-text-editor\" data-id=\"d8c93ea\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00abPRIMA \u00e8 indicato per i pazienti con <\/span><b>degenerazione maculare legata all&#8217;et\u00e0 in forma atrofica avanzata<\/b><span style=\"font-weight: 400;\"> (<\/span><b>atrofia geografica<\/b><span style=\"font-weight: 400;\">) che hanno subito la <\/span><b>perdita della visione centrale<\/b><span style=\"font-weight: 400;\">. In Italia il dispositivo potrebbe essere impiantato nelle strutture sanitarie pubbliche secondo i percorsi previsti nel nostro Paese, previa definizione delle modalit\u00e0 di accesso e di eventuale rimborsabilit\u00e0 da parte del Servizio Sanitario Nazionale. Si stima che in Italia i pazienti che potrebbero trarne beneficio siano tra 150.000 e 170.000, ma l&#8217;indicazione dovr\u00e0 essere valutata caso per caso dai centri specialistici.\u00bb<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6860234 elementor-widget elementor-widget-heading\" data-id=\"6860234\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Cosa sappiamo sui costi e sull'accesso all\u2019impianto?\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9c926d5 elementor-widget elementor-widget-text-editor\" data-id=\"9c926d5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00abIl costo definitivo del dispositivo non \u00e8 stato ancora reso noto. L&#8217;ottenimento del marchio CE rende per\u00f2 possibile l&#8217;introduzione della tecnologia nelle strutture sanitarie pubbliche e apre la strada a futuri percorsi di rimborsabilit\u00e0 da parte del Servizio Sanitario Nazionale, secondo le procedure previste.\u00bb<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b741434 elementor-widget elementor-widget-spacer\" data-id=\"b741434\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b85bac4 elementor-widget elementor-widget-heading\" data-id=\"b85bac4\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">PRIMA potrebbe avere benefici anche per la comunit\u00e0?<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c2f09c6 elementor-widget elementor-widget-text-editor\" data-id=\"c2f09c6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00abCertamente, se confermer\u00e0 i benefici osservati negli studi clinici, la tecnologia di PRIMA potr\u00e0 rappresentare non solo un&#8217;opportunit\u00e0 per i pazienti, ma anche un potenziale vantaggio per il sistema sanitario, contribuendo a ridurre i costi assistenziali legati alla disabilit\u00e0 visiva.\u00bb<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d0ca80c elementor-widget elementor-widget-text-editor\" data-id=\"d0ca80c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Da quanto noto ed emerso finora, con l\u2019approvazione del marchio CE per la tecnologia PRIMA ci troviamo di fronte a una nuova era del trattamento della maculopatia atrofica. L&#8217;introduzione di PRIMA nella pratica clinica segna da un lato un importante traguardo ma, allo stesso tempo, anche un nuovo punto di partenza per la ricerca sulle protesi retiniche e per la loro ulteriore evoluzione.<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-91aa614 elementor-widget elementor-widget-spacer\" data-id=\"91aa614\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-64d1e18 elementor-widget elementor-widget-spacer\" data-id=\"64d1e18\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-892c36d elementor-widget elementor-widget-spacer\" data-id=\"892c36d\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6a01fde elementor-widget elementor-widget-spacer\" data-id=\"6a01fde\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-99b4c08 elementor-widget elementor-widget-spacer\" data-id=\"99b4c08\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b7c6a9f elementor-widget elementor-widget-spacer\" data-id=\"b7c6a9f\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ab68a18 elementor-widget elementor-widget-spacer\" data-id=\"ab68a18\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e034a83 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e034a83\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-6d2453c\" data-id=\"6d2453c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a36c027 elementor-widget elementor-widget-spacer\" data-id=\"a36c027\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6a52068 elementor-widget elementor-widget-spacer\" data-id=\"6a52068\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fe81d83 elementor-widget elementor-widget-spacer\" data-id=\"fe81d83\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-1216dd3\" data-id=\"1216dd3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c41ec05 elementor-widget elementor-widget-text-editor\" data-id=\"c41ec05\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>Dr. Jung Hee Levialdi Ghiron<br \/><strong>Responsabile comunicazione scientifica Rome Vision Clinic<\/strong><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Tabella dei Contenuti PRIMA \u00e8 una tecnologia d\u2019avanguardia progettata e realizzata per il trattamento dei pazienti affetti da degenerazione maculare legata all&#8217;et\u00e0 (maculopatia) di tipo atrofico evoluta allo stadio terminale di atrofia geografica. L&#8217;ottenimento del marchio CE e il conseguente via libera alla sua commercializzazione permetteranno a PRIMA di entrare nella pratica clinica. Cosa significa&#8230;<\/p>\n","protected":false},"author":13,"featured_media":17408,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[63],"tags":[],"class_list":["post-17407","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-novita","nt-post-class","","masonry-item","col-lg-4","excerpt-none"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata -\" \/>\n<meta property=\"og:description\" content=\"Tabella dei Contenuti PRIMA \u00e8 una tecnologia d\u2019avanguardia progettata e realizzata per il trattamento dei pazienti affetti da degenerazione maculare legata all&#8217;et\u00e0 (maculopatia) di tipo atrofico evoluta allo stadio terminale di atrofia geografica. L&#8217;ottenimento del marchio CE e il conseguente via libera alla sua commercializzazione permetteranno a PRIMA di entrare nella pratica clinica. Cosa significa...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/\" \/>\n<meta property=\"og:site_name\" content=\"Rome Vision Clinic\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-06T08:04:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T11:31:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"556\" \/>\n\t<meta property=\"og:image:height\" content=\"414\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luca Mandolesi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luca Mandolesi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/\",\"url\":\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/\",\"name\":\"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata -\",\"isPartOf\":{\"@id\":\"https:\/\/romevisionclinic.com\/it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg\",\"datePublished\":\"2026-08-06T08:04:38+00:00\",\"dateModified\":\"2026-09-08T11:31:47+00:00\",\"author\":{\"@id\":\"https:\/\/romevisionclinic.com\/it\/#\/schema\/person\/5d78e47feee5ef89d98dd41b3fee3ff4\"},\"breadcrumb\":{\"@id\":\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#primaryimage\",\"url\":\"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg\",\"contentUrl\":\"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg\",\"width\":556,\"height\":414},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/romevisionclinic.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/romevisionclinic.com\/it\/#website\",\"url\":\"https:\/\/romevisionclinic.com\/it\/\",\"name\":\"Rome Vision Clinic\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/romevisionclinic.com\/it\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/romevisionclinic.com\/it\/#\/schema\/person\/5d78e47feee5ef89d98dd41b3fee3ff4\",\"name\":\"Luca Mandolesi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/romevisionclinic.com\/it\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c60b98e9d6ab06e60b50f5d234cd9a22d91ba9b403c588fd91bed92f078a1a2b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c60b98e9d6ab06e60b50f5d234cd9a22d91ba9b403c588fd91bed92f078a1a2b?s=96&d=mm&r=g\",\"caption\":\"Luca Mandolesi\"},\"url\":\"https:\/\/romevisionclinic.com\/it\/author\/luca_mandolesi\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/","og_locale":"it_IT","og_type":"article","og_title":"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata -","og_description":"Tabella dei Contenuti PRIMA \u00e8 una tecnologia d\u2019avanguardia progettata e realizzata per il trattamento dei pazienti affetti da degenerazione maculare legata all&#8217;et\u00e0 (maculopatia) di tipo atrofico evoluta allo stadio terminale di atrofia geografica. L&#8217;ottenimento del marchio CE e il conseguente via libera alla sua commercializzazione permetteranno a PRIMA di entrare nella pratica clinica. Cosa significa...","og_url":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/","og_site_name":"Rome Vision Clinic","article_published_time":"2026-08-06T08:04:38+00:00","article_modified_time":"2026-09-08T11:31:47+00:00","og_image":[{"width":556,"height":414,"url":"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg","type":"image\/jpeg"}],"author":"Luca Mandolesi","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Luca Mandolesi","Tempo di lettura stimato":"5 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/","url":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/","name":"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata -","isPartOf":{"@id":"https:\/\/romevisionclinic.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#primaryimage"},"image":{"@id":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#primaryimage"},"thumbnailUrl":"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg","datePublished":"2026-08-06T08:04:38+00:00","dateModified":"2026-09-08T11:31:47+00:00","author":{"@id":"https:\/\/romevisionclinic.com\/it\/#\/schema\/person\/5d78e47feee5ef89d98dd41b3fee3ff4"},"breadcrumb":{"@id":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#primaryimage","url":"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg","contentUrl":"https:\/\/romevisionclinic.com\/wp-content\/uploads\/2026\/08\/protesi.jpg","width":556,"height":414},{"@type":"BreadcrumbList","@id":"https:\/\/romevisionclinic.com\/it\/protesi-sottoretinica-marchio-ce\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/romevisionclinic.com\/it\/"},{"@type":"ListItem","position":2,"name":"La protesi sottoretinica PRIMA ottiene il marchio CE: cosa cambia per i pazienti con degenerazione maculare atrofica avanzata"}]},{"@type":"WebSite","@id":"https:\/\/romevisionclinic.com\/it\/#website","url":"https:\/\/romevisionclinic.com\/it\/","name":"Rome Vision Clinic","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/romevisionclinic.com\/it\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/romevisionclinic.com\/it\/#\/schema\/person\/5d78e47feee5ef89d98dd41b3fee3ff4","name":"Luca Mandolesi","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/romevisionclinic.com\/it\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c60b98e9d6ab06e60b50f5d234cd9a22d91ba9b403c588fd91bed92f078a1a2b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c60b98e9d6ab06e60b50f5d234cd9a22d91ba9b403c588fd91bed92f078a1a2b?s=96&d=mm&r=g","caption":"Luca Mandolesi"},"url":"https:\/\/romevisionclinic.com\/it\/author\/luca_mandolesi\/"}]}},"_links":{"self":[{"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/posts\/17407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/comments?post=17407"}],"version-history":[{"count":10,"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/posts\/17407\/revisions"}],"predecessor-version":[{"id":17587,"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/posts\/17407\/revisions\/17587"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/media\/17408"}],"wp:attachment":[{"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/media?parent=17407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/categories?post=17407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/romevisionclinic.com\/it\/wp-json\/wp\/v2\/tags?post=17407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}